Multi-omics methods in developing biomarkers of MASLD: Genomics and transcriptomics
Genomic and transcriptomic biomarkers represent important factors in the pathogenic processes of MASLD and offer promise as a non-invasive alternative to liver biopsy for disease diagnosis, staging, and longitudinal monitoring.